Prominent features of management strategies in acute coronary syndromes with the new oral antiplatelet agents

The novel oral P2Y12 inhibitors (prasugrel and ticagrelor) have been incorporated into the recently updated acute coronary syndrome (ACS) guidelines, as an adjunct antiplatelet treatment to aspirin. The studies involving the use of new oral antiplatelet agents that are more potent, predictable and f...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: Rasim Enar (Автор)
Формат:
Опубликовано: KARE Publishing, 2013-04-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

Connect to this object online.

3rd Floor Main Library

Подробно о фондах из 3rd Floor Main Library
Шифр: A1234.567
Копировать 1 Доступно